Variant report

Variant	nsv433369
Chromosome Location	chr5:1644735-1656054
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:9)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr5:1559974..1562443-chr5:1642820..1645262,2	K562	blood:
2	chr5:1380129..1381053-chr5:1644702..1645623,2	K562	blood:
3	chr5:1648921..1651237-chr5:1656586..1659159,2	MCF-7	breast:
4	chr5:1167994..1168516-chr5:1644707..1645648,2	MCF-7	breast:
5	chr5:1652097..1654972-chr5:1657057..1658557,2	K562	blood:
6	chr5:1601386..1602232-chr5:1644668..1645654,3	MCF-7	breast:
7	chr5:1479406..1480370-chr5:1644706..1645695,7	K562	blood:
8	chr5:1651364..1654972-chr5:1656341..1659968,4	K562	blood:
9	chr5:1208740..1209449-chr5:1644991..1645637,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000250584	chromatin interactions

Extended variants
information (count: 510 )
Associated
traits (count: 115 )

Variant overlapped rSNPs/rCNVs (count:510 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs11738727	chr5:1644766-1644767	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs6554918	chr5:1644785-1644786	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs1875191	chr5:1644831-1644832	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs4990323	chr5:1644850-1644851	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs1875192	chr5:1644915-1644916	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs535858686	chr5:1644958-1644959	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs4082658	chr5:1644961-1644962	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs11745485	chr5:1644980-1644981	Bivalent/Poised TSS Bivalent Enhancer Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs569936199	chr5:1645033-1645034	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers ZNF genes & repeats	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs536992087	chr5:1645034-1645035	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers ZNF genes & repeats	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs34655275	chr5:1645045-1645046	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers ZNF genes & repeats	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs4510616	chr5:1645053-1645054	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers ZNF genes & repeats	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs558881591	chr5:1645055-1645056	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers ZNF genes & repeats	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs34053127	chr5:1645091-1645092	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers ZNF genes & repeats	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs35127340	chr5:1645096-1645097	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers ZNF genes & repeats	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs577143076	chr5:1645105-1645106	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers ZNF genes & repeats	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs114709986	chr5:1645110-1645111	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers ZNF genes & repeats	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs553124174	chr5:1645116-1645117	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers ZNF genes & repeats	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs12153695	chr5:1645118-1645119	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers ZNF genes & repeats	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
20	rs541816642	chr5:1645128-1645129	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers ZNF genes & repeats	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs563088693	chr5:1645133-1645134	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers ZNF genes & repeats	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs530520989	chr5:1645134-1645135	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers ZNF genes & repeats	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs546125050	chr5:1645156-1645157	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Weak transcription Enhancers ZNF genes & repeats	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs564419067	chr5:1645226-1645227	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS ZNF genes & repeats Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs4551124	chr5:1645242-1645243	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS ZNF genes & repeats Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs546757720	chr5:1645293-1645294	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS ZNF genes & repeats Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs568551626	chr5:1645299-1645300	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS ZNF genes & repeats Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs113683172	chr5:1645326-1645327	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS ZNF genes & repeats Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs551050574	chr5:1645340-1645341	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS ZNF genes & repeats Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs569196359	chr5:1645360-1645361	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS ZNF genes & repeats Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs539803726	chr5:1645361-1645362	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS ZNF genes & repeats Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs558918390	chr5:1645363-1645364	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS ZNF genes & repeats Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs116152894	chr5:1645371-1645372	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS ZNF genes & repeats Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs11133842	chr5:1645386-1645387	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS ZNF genes & repeats Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
35	rs186728002	chr5:1645425-1645426	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS ZNF genes & repeats Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
36	rs574475424	chr5:1645428-1645429	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS ZNF genes & repeats Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
37	rs147473967	chr5:1645516-1645517	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS ZNF genes & repeats Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
38	rs576803438	chr5:1645532-1645533	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS ZNF genes & repeats Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
39	rs140000261	chr5:1645544-1645545	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS ZNF genes & repeats Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
40	rs145475231	chr5:1645556-1645557	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS ZNF genes & repeats Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
41	rs79651051	chr5:1645575-1645576	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS ZNF genes & repeats Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
42	rs543889030	chr5:1645577-1645578	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS ZNF genes & repeats Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
43	rs191139532	chr5:1645579-1645580	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS ZNF genes & repeats Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs573161496	chr5:1645672-1645673	Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs62335940	chr5:1645673-1645674	Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs183269521	chr5:1645680-1645681	Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs62335941	chr5:1645686-1645687	Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs5865376	chr5:1645707-1645708	Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs397780079	chr5:1645709-1645710	Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs550828565	chr5:1645748-1645749	Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:115)

Disease	PMID	Source
Biliary cancer	19435499	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16608533	CNVD
Cervical cancer	16585170	CNVD
Glioblastoma multiforme	22286061	CNVD
Lung cancer	17925434	CNVD
Ovarian cancer	20844748	CNVD
Cervical squamous cell carcinoma	21590768	CNVD
Non-small cell lung cancer	21829676	CNVD
Intracranial ependymoma	16609018	CNVD
Breast cancer	19181860	CNVD
prenatal diagnosis	20453657	CNVD
Developmental delay	19490664	CNVD
Human papillomavirus	17975027	CNVD
Acute monocytic leukemia	16498392	CNVD
Gastric cancer	16891809	CNVD
Intracranial aneurysm	16715129	CNVD
Emphysema	19352772	CNVD
Chordoma	18071362	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Lung cancer	21911935	CNVD
Cri-du chat syndrome	21549014	CNVD
Melanoma	18172304	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Sudden cardiac death	19188705	CNVD
renal disease	17924346	CNVD
abnormal development	18461090	CNVD
Lung cancer	19547694	CNVD
Cri-du chat syndrome	22283845	CNVD
Disorders of sex development	21048976	CNVD
Non-small cell lung cancer	20864512	CNVD
Cancer	21183584	CNVD
Honadal dysgenesis	21048976	CNVD
Cancer	16751803	CNVD
Breast cancer	17133270	CNVD
Hepatocellular carcinoma	22174799	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Salivary gland tumor	18059337	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Kartagener syndrome	16639409	CNVD
Medulloblastoma	21979893	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	16783165	CNVD
Thyroid cancer	19087340	CNVD
Liposarcoma	21253554	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Cervical Cancer	21857958	CNVD
Cervical cancer	21062161	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Ewing''s sarcoma	17952124	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Cervical cancer	18559093	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Colorectal cancer	21645411	CNVD
Gastric cancer	22152101	CNVD
Oesophago-gastric ulcer	22152101	CNVD
Ovarian cancer	21781307	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	21509527	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Breast cancer	21364760	CNVD
Cancer	20164919	CNVD
Oral cancer	22144094	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Urothelial carcinoma	21177765	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Multiple myeloma	17550852	CNVD
Pleomorphic liposarcoma	18784837	CNVD
Developmental delay	21147756	CNVD
prenatal diagnosis	22389664	CNVD
Bladder cancer	21909424	CNVD
DNA damage stimulus	22844521	CNVD
DNA repair	22844521	CNVD
Breast cancer	21785460	CNVD
Spinal muscular atrophy	22422766	CNVD
Spinal muscular atrophy	22558076	CNVD
Spinal muscular atrophy	21320981	CNVD
Spinal muscular atrophy	21762474	CNVD
Breast cancer	21858162	CNVD
Prostate cancer	18632612	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Melanoma	22183965	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
XY gonadal dysgenesis	20685758	CNVD
lymphocytic leukemia	21291569	CNVD
Autism	22495311	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Breast cancer	22522925	CNVD
Intellectual disability	21811512	CNVD
Lung adenocarcinoma	21935476	CNVD

Chromatin state (count:438 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:1634600-1645000	Weak transcription	Right Atrium	heart
2	chr5:1634600-1645200	Weak transcription	Gastric	stomach
3	chr5:1643600-1645000	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
4	chr5:1643600-1645000	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
5	chr5:1643600-1645600	Bivalent Enhancer	Primary T killer naive cells fromperipheralblood	blood
6	chr5:1644000-1644800	Bivalent/Poised TSS	Hela-S3	cervix
7	chr5:1644000-1645200	Bivalent Enhancer	Primary T killer memory cells from peripheral blood	blood
8	chr5:1644200-1645000	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 2	blood
9	chr5:1644200-1645400	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 1	blood
10	chr5:1644200-1645600	Bivalent Enhancer	Primary T helper naive cells from peripheral blood	blood
11	chr5:1644200-1645800	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
12	chr5:1644400-1644800	Bivalent Enhancer	Fetal Brain Female	brain
13	chr5:1644400-1645000	Bivalent Enhancer	Duodenum Mucosa	Duodenum
14	chr5:1644400-1645000	Bivalent Enhancer	Stomach Smooth Muscle	stomach
15	chr5:1644400-1645200	Bivalent Enhancer	Primary T cells effector/memory enriched fromperipheralblood	blood
16	chr5:1644400-1645200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
17	chr5:1644400-1645200	Bivalent Enhancer	Brain Hippocampus Middle	brain
18	chr5:1644400-1645200	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
19	chr5:1644400-1645400	Bivalent/Poised TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
20	chr5:1644400-1645400	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
21	chr5:1644400-1645400	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
22	chr5:1644400-1645600	Bivalent Enhancer	Primary B cells from peripheral blood	blood
23	chr5:1644400-1645600	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
24	chr5:1644400-1645800	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
25	chr5:1644400-1645800	Bivalent Enhancer	Primary B cells from cord blood	blood
26	chr5:1644600-1645000	Bivalent Enhancer	Primary T regulatory cells fromperipheralblood	blood
27	chr5:1644600-1645000	Bivalent Enhancer	HepG2	liver
28	chr5:1644600-1645200	Bivalent/Poised TSS	Primary T helper naive cells fromperipheralblood	blood
29	chr5:1644600-1645400	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
30	chr5:1644600-1645400	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
31	chr5:1644600-1645600	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
32	chr5:1644600-1645600	Enhancers	Dnd41	blood
33	chr5:1644600-1645800	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
34	chr5:1644800-1645000	Bivalent Enhancer	Hela-S3	cervix
35	chr5:1645000-1645200	Bivalent/Poised TSS	iPS DF 19.11 Cell Line	embryonic stem cell
36	chr5:1645000-1645200	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
37	chr5:1645000-1645200	Bivalent Enhancer	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
38	chr5:1645000-1645200	Bivalent/Poised TSS	Primary T cells from cord blood	blood
39	chr5:1645000-1645200	Flanking Bivalent TSS/Enh	Primary T cells fromperipheralblood	blood
40	chr5:1645000-1645200	Flanking Bivalent TSS/Enh	Primary T helper memory cells from peripheral blood 2	blood
41	chr5:1645000-1645200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
42	chr5:1645000-1645200	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
43	chr5:1645000-1645200	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
44	chr5:1645000-1645200	Bivalent Enhancer	Adipose Nuclei	Adipose
45	chr5:1645000-1645200	Active TSS	Brain Anterior Caudate	brain
46	chr5:1645000-1645200	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
47	chr5:1645000-1645200	Bivalent Enhancer	Fetal Brain Male	brain
48	chr5:1645000-1645200	Bivalent/Poised TSS	Fetal Brain Female	brain
49	chr5:1645000-1645200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
50	chr5:1645000-1645200	Bivalent Enhancer	Fetal Muscle Leg	muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links